or Try an Advanced Search...

    Technical Analysis for EVOK - Evoke Pharma, Inc.

    Grade Last Price % Change Price Change
    F 0.47 -1.04% 0.00
    EVOK closed down 1.04 percent on Friday, May 17, 2024, on approximately normal volume.
    Earnings due: May 22
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical EVOK trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    20 DMA Support Bullish -1.04%
    New Uptrend Bullish -1.04%
    Bollinger Band Squeeze Range Contraction -1.04%
    BB Squeeze + Upper Band Touch Range Contraction -1.04%
    Outside Day Range Expansion -1.04%
    Older End-of-Day Signals for EVOK ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 1 day ago
    Possible Inside Day 1 day ago
    Rose Above Upper Bollinger Band 1 day ago
    Rose Above 10 DMA 1 day ago
    Up 5% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    EVOK Chart by TradingView
    Basic chart:

    Profile

    Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers

    Is EVOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
    Mar 16 Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
    Mar 15 Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
    Mar 15 Q4 2023 Evoke Pharma Inc Earnings Call
    Mar 15 Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript
    Mar 14 Evoke Pharma GAAP EPS of -$0.59 revenue of $1.7M
    Mar 14 Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 14 Earnings Scheduled For March 14, 2024
    Mar 13 A Preview Of Evoke Pharma's Earnings
    Mar 7 Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
    See more EVOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.158
    52 Week Low 0.4104
    Average Volume 31,617
    200-Day Moving Average 0.94
    50-Day Moving Average 0.54
    20-Day Moving Average 0.46
    10-Day Moving Average 0.47
    Average True Range 0.06
    RSI (14) 42.86
    ADX 26.61
    +DI 21.64
    -DI 8.28
    Chandelier Exit (Long, 3 ATRs) 0.40
    Chandelier Exit (Short, 3 ATRs) 0.58
    Upper Bollinger Bands 0.49
    Lower Bollinger Band 0.44
    Percent B (%b) 0.55
    BandWidth 11.34
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.006
    Fundamentals Value
    Market Cap 1.55 Million
    Num Shares 3.34 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -0.20
    Price-to-Sales 0.58
    Price-to-Book 1.79
    PEG Ratio -0.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.53
    Resistance 3 (R3) 0.53 0.52 0.52
    Resistance 2 (R2) 0.52 0.50 0.51 0.51
    Resistance 1 (R1) 0.49 0.49 0.48 0.49 0.51
    Pivot Point 0.47 0.47 0.47 0.47 0.47
    Support 1 (S1) 0.45 0.46 0.44 0.44 0.42
    Support 2 (S2) 0.43 0.45 0.43 0.42
    Support 3 (S3) 0.41 0.43 0.41
    Support 4 (S4) 0.40